Year |
Citation |
Score |
2023 |
McDaniel CG, Adams DM, Steele KE, Hammill AM, Merrow AC, Crane JE, Smith CL, Kozakewich HPW, Le Cras TD. Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. Pediatric Blood & Cancer. e30219. PMID 36683202 DOI: 10.1002/pbc.30219 |
0.534 |
|
2023 |
Engel ER, Hammill A, Adams D, Phillips RJ, Jeng M, Tollefson MM, Iacobas I, Schiff D, Greenberger S, Kelly M, Frieden I, Zaghloul N, Drolet B, Geddis A, Goldenberg D, et al. Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatric Blood & Cancer. e30215. PMID 36651691 DOI: 10.1002/pbc.30215 |
0.533 |
|
2022 |
Blei F, Adams D, Brandao LR, Trenor C, Iacobas I, Hammill A. It is timely and exciting that Pediatric Blood and Cancer has endorsed a supplement dedicated to Vascular Anomalies. Pediatric Blood & Cancer. e29796. PMID 35686828 DOI: 10.1002/pbc.29796 |
0.483 |
|
2021 |
Canaud G, Hammill AM, Adams D, Vikkula M, Keppler-Noreuil KM. A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet Journal of Rare Diseases. 16: 306. PMID 34238334 DOI: 10.1186/s13023-021-01929-8 |
0.516 |
|
2021 |
Canaud G, López Gutiérrez JC, Hammill AM, Weibel L, Vincent G, Niglis S, Paul M, Adams DM. EPIK-P2: A prospective phase 2, double-blind, randomized, placebo-controlled study of alpelisib in pediatric and adult patients (Pts) with PIK3CA-related overgrowth spectrum (PROS). Journal of Clinical Oncology. 39: TPS3160-TPS3160. DOI: 10.1200/JCO.2021.39.15_SUPPL.TPS3160 |
0.526 |
|
2020 |
Eng W, Hammill AM, Adams DM. Overgrowth syndromes and new therapies. Seminars in Pediatric Surgery. 29: 150974. PMID 33069285 DOI: 10.1016/j.sempedsurg.2020.150974 |
0.53 |
|
2020 |
Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, ... ... Hammill A, et al. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Annals of Internal Medicine. PMID 32894695 DOI: 10.7326/M20-1443 |
0.306 |
|
2020 |
Ricci KW, Chute C, Hammill AM, Dasgupta R, Patel M. Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy. Pediatric Blood & Cancer. e28277. PMID 32779831 DOI: 10.1002/Pbc.28277 |
0.323 |
|
2020 |
Le Cras TD, Goines J, Lakes N, Pastura P, Hammill AM, Adams DM, Boscolo E. Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. Angiogenesis. PMID 32350708 DOI: 10.1007/S10456-020-09722-0 |
0.593 |
|
2020 |
Shin SM, Kim HK, Crotty EJ, Hammill AM, Wusik K, Kim DH. CT Angiography Findings of Pulmonary Arteriovenous Malformations in Children and Young Adults With Hereditary Hemorrhagic Telangiectasia. Ajr. American Journal of Roentgenology. 1-8. PMID 32255688 DOI: 10.2214/Ajr.19.22012 |
0.306 |
|
2020 |
Badia P, Ricci K, Gurria JP, Dasgupta R, Patel M, Hammill A. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series. Pediatric Blood & Cancer. e28088. PMID 31930696 DOI: 10.1002/Pbc.28088 |
0.393 |
|
2020 |
Fernández KS, de Alarcon A, Adams DM, Hammill AM. Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma. Pediatric Blood & Cancer. e28162. PMID 31925925 DOI: 10.1002/Pbc.28162 |
0.576 |
|
2019 |
Boscolo E, Pastura P, Glaser K, Goines J, Hammill AM, Adams DM, Dickie P, Hsi Dickie B, Le Cras TD. Signaling pathways and inhibitors of cells from patients with kaposiform lymphangiomatosis. Pediatric Blood & Cancer. e27790. PMID 31045327 DOI: 10.1002/Pbc.27790 |
0.547 |
|
2019 |
Ricci KW, Hammill AM, Mobberley-Schuman P, Nelson SC, Blatt J, Bender JLG, McCuaig CC, Synakiewicz A, Frieden IJ, Adams DM. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease. Pediatric Blood & Cancer. e27614. PMID 30672136 DOI: 10.1002/Pbc.27614 |
0.558 |
|
2018 |
Polites SF, Watanabe M, Crafton T, Jenkins TM, Alvarez-Allende CR, Hammill AM, Dasgupta R. Surgical resection of infantile hemangiomas following medical treatment with propranolol versus corticosteroids. Journal of Pediatric Surgery. PMID 30249358 DOI: 10.1016/J.Jpedsurg.2018.08.001 |
0.302 |
|
2018 |
Iacobas I, Phung TL, Adams DM, Trenor CC, Blei F, Fishman DS, Hammill A, Masand PM, Fishman SJ. Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. The Journal of Pediatrics. PMID 30244993 DOI: 10.1016/J.Jpeds.2018.08.012 |
0.528 |
|
2018 |
Goines J, Li X, Cai Y, Mobberley-Schuman P, Metcalf M, Fishman SJ, Adams DM, Hammill AM, Boscolo E. A xenograft model for venous malformation. Angiogenesis. PMID 29786783 DOI: 10.1007/S10456-018-9624-7 |
0.586 |
|
2018 |
Scorletti F, Hammill A, Patel M, Ricci K, Dasgupta R. Malignant tumors misdiagnosed as benign vascular anomalies. Pediatric Blood & Cancer. e27051. PMID 29630783 DOI: 10.1002/Pbc.27051 |
0.329 |
|
2018 |
Scorletti F, Patel MN, Hammill AM, Ricci KW, Myer CM, Dasgupta R. Sclerotherapy for intramuscular vascular malformations: A single-center experience. Journal of Pediatric Surgery. PMID 29519571 DOI: 10.1016/J.Jpedsurg.2018.02.040 |
0.322 |
|
2017 |
Mizuno T, Emoto C, Fukuda T, Hammill AM, Adams DM, Vinks AA. Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28526601 DOI: 10.1016/J.Ejps.2017.05.037 |
0.56 |
|
2017 |
Visscher MO, Burkes SA, Adams DM, Hammill AM, Wickett RR. Infant skin maturation: Preliminary outcomes for color and biomechanical properties. Skin Research and Technology : Official Journal of International Society For Bioengineering and the Skin (Isbs) [and] International Society For Digital Imaging of Skin (Isdis) [and] International Society For Skin Imaging (Issi). PMID 28303612 DOI: 10.1111/Srt.12369 |
0.507 |
|
2017 |
Mizuno T, Fukuda T, Emoto C, Mobberley-Schuman PS, Hammill AM, Adams DM, Vinks AA. Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies. Pediatric Blood & Cancer. PMID 28205374 DOI: 10.1002/Pbc.26470 |
0.543 |
|
2016 |
Hammill A, Mobberley-Schuman P, Adams D. Lymphoedema is a potential sequela of Kaposiform Hemangioendothelioma. The British Journal of Dermatology. PMID 27291923 DOI: 10.1111/Bjd.14810 |
0.525 |
|
2016 |
Salloum R, Fox CE, Alvarez-Allende CR, Hammill AM, Dasgupta R, Dickie BH, Mobberley-Schuman P, Wentzel MS, Chute C, Kaul A, Patel M, Merrow AC, Gupta A, Whitworth JR, Adams DM. Response of Blue Rubber Bleb Nevus Syndrome to Sirolimus Treatment. Pediatric Blood & Cancer. PMID 27273326 DOI: 10.1002/Pbc.26049 |
0.551 |
|
2016 |
Comi AM, Sahin M, Hammill A, Kaplan EH, Juhász C, North P, Ball KL, Levin AV, Cohen B, Morris J, Lo W, Roach ES. Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research. Pediatric Neurology. 58: 12-24. PMID 27268758 DOI: 10.1016/J.Pediatrneurol.2015.11.009 |
0.321 |
|
2016 |
Burkes SA, Patel M, Adams DM, Hammill AM, Eaton KP, Randall Wickett R, Visscher MO. Infantile hemangioma status by dynamic infrared thermography: A preliminary study. International Journal of Dermatology. PMID 27062495 DOI: 10.1111/Ijd.13298 |
0.535 |
|
2016 |
Adams DM, Trenor CC, Hammill AM, Vinks AA, Patel MN, Chaudry G, Wentzel MS, Mobberley-Schuman PS, Campbell LM, Brookbank C, Gupta A, Chute C, Eile J, McKenna J, Merrow AC, et al. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Pediatrics. PMID 26783326 DOI: 10.1542/Peds.2015-3257 |
0.578 |
|
2015 |
Adams DM, Hammill AM, Mobberley-Schuman PS, Trenor CC. Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up. Pediatric Blood & Cancer. 62: 2056. PMID 26052679 DOI: 10.1002/pbc.25609 |
0.463 |
|
2015 |
Burkes SA, Adams DM, Hammill AM, Chute C, Eaton KP, Welge JA, Wickett RR, Visscher MO. Skin imaging modalities quantify progression and stage of infantile haemangiomas. The British Journal of Dermatology. 173: 838-41. PMID 25975196 DOI: 10.1111/Bjd.13905 |
0.502 |
|
2015 |
Turpin B, Karns R, Sarangdhar M, Weiss BD, Geller JI, Absalon M, O'Brien MM, Nagarajan R, Phillips CL, Chow LM, DeWire MD, Adams D, Burns KC, Hummel TR, Fouladi M, ... Hammill AM, et al. Next generation sequencing (NGS) to identify targetable recurring mutations and exceptional responders in relapsed and high-risk childhood and adolescent/young adult (AYA) malignancies. Journal of Clinical Oncology. 33: 11011-11011. DOI: 10.1200/Jco.2015.33.15_Suppl.11011 |
0.541 |
|
2014 |
Adams DM, Hammill A. Other vascular tumors. Seminars in Pediatric Surgery. 23: 173-7. PMID 25241094 DOI: 10.1053/J.Sempedsurg.2014.07.001 |
0.542 |
|
2014 |
Jeng MR, Fuh B, Blatt J, Gupta A, Merrow AC, Hammill A, Adams D. Malignant transformation of infantile hemangioma to angiosarcoma: response to chemotherapy with bevacizumab. Pediatric Blood & Cancer. 61: 2115-7. PMID 24740626 DOI: 10.1002/Pbc.25067 |
0.571 |
|
2013 |
Drolet BA, Trenor CC, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, et al. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. The Journal of Pediatrics. 163: 285-91. PMID 23796341 DOI: 10.1016/J.Jpeds.2013.03.080 |
0.612 |
|
2011 |
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatric Blood & Cancer. 57: 1018-24. PMID 21445948 DOI: 10.1002/Pbc.23124 |
0.589 |
|
2002 |
Hsueh RC, Hammill AM, Lee JA, Uhr JW, Scheuermann RH. Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. Bmc Immunology. 3: 16. PMID 12470302 DOI: 10.1186/1471-2172-3-16 |
0.496 |
|
Show low-probability matches. |